# Reduced Intensity Donor Stem Cell Transplant in Treating Patients With High Risk Acute Lymphocytic Leukemia in Complete Remission

> **NCT00031655** · PHASE2 · COMPLETED · sponsor: **Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium** · enrollment: 30 (estimated)

## Conditions studied

- Adult Acute Lymphoblastic Leukemia in Remission
- Childhood Acute Lymphoblastic Leukemia in Remission
- Recurrent Adult Acute Lymphoblastic Leukemia
- Recurrent Childhood Acute Lymphoblastic Leukemia

## Interventions

- **PROCEDURE:** nonmyeloablative allogeneic hematopoietic stem cell transplantation
- **BIOLOGICAL:** donor lymphocytes
- **DRUG:** cyclosporine
- **RADIATION:** total-body irradiation
- **DRUG:** fludarabine phosphate
- **DRUG:** mycophenolate mofetil
- **OTHER:** laboratory biomarker analysis
- **PROCEDURE:** peripheral blood stem cell transplantation

## Key facts

- **NCT ID:** NCT00031655
- **Lead sponsor:** Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-09
- **Primary completion:** 2006-08
- **Final completion:** 2012-11
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2012-12-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00031655

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00031655, "Reduced Intensity Donor Stem Cell Transplant in Treating Patients With High Risk Acute Lymphocytic Leukemia in Complete Remission". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00031655. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*